Ming Yu

Ming Yu has a diverse work experience in the field of biosciences. Currently, Ming Yu holds the position of Scientist II at Alamar Biosciences, Inc. Since 2022. Prior to that, Ming Yu worked as a Scientist II at Akoya Biosciences, Inc. from September to December 2021.

Before joining Akoya Biosciences, Ming Yu worked as a Senior Research Associate at Advanced Cell Diagnostics from September 2019 to October 2021.

From 2017 to 2019, Ming Yu served as the Co-Director of Case Management at MORE Health Inc. During this time, Ming Yu managed over 120 medical assignments and delivered concierge medical service. Ming Yu also held the position of Senior Case Manager, overseeing the planning, scheduling, and control of case activities.

Ming Yu's previous experience includes a position as a Postdoctoral Researcher at Purdue University from June 2016 to May 2017. The major project involved developing an RNA interference-based therapeutic approach for liver disease patients with specific genetic risk alleles.

Before that, Ming Yu worked as a Postdoctoral Researcher at the University of Pennsylvania from June 2015 to May 2016. The major project focused on genetic engineering for genes related to human muscle weakness.

Starting in 2009, Ming Yu worked at Oklahoma State University as a Research Assistant until June 2015. The research primarily focused on the genetic bases and molecular mechanisms of the developmental process. Ming Yu also served as a Teaching Assistant for the course "Applied Genomics" in 2010.

Overall, Ming Yu's work experience spans various roles and responsibilities within the field of biosciences.

Ming Yu began their education at Shandong Agricultural University, where they obtained a Bachelor's Degree in Biotechnology from 2005 to 2009. They then pursued further studies at Oklahoma State University, earning a Master's Degree in Plant Science from 2009 to 2011. Ming Yu continued their academic journey at the same university and obtained a Doctor of Philosophy (Ph.D.) in Molecular Biology from 2011 to 2015. Recently, they attended the International Technological University (ITU) from 2018 to 2020, where they completed a Master of Business Administration (MBA) with a focus on Healthcare.